Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein

Figure 5

Analysis of differences in the tumor microenvironment (TME) and tumor mutational burden (TMB) between high- and low-risk groups: (a) immune score; (b) stromal score; (c) tumor purity; (d) tumor mutational burden.

(a)

(b)

(c)

(d)